Chugai Pharmaceutical Co., Ltd. (CHGCY) Financials
CHGCY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 14.2 billion | 2.2 billion |
| Dec. 31, 2025 | 15.8 billion | 2.8 billion |
| Sept. 30, 2025 | 15.0 billion | 2.0 billion |
| June 30, 2025 | 15.8 billion | 2.0 billion |
CHGCY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 705.8 million | ? |
| Dec. 31, 2025 | 748.6 million | ? |
| Sept. 30, 2025 | 436.5 million | ? |
| June 30, 2025 | 643.8 million | ? |
CHGCY Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | 735.9 million |
| Dec. 31, 2025 | 834.5 million |
| Sept. 30, 2025 | 764.5 million |
| June 30, 2025 | 675.6 million |
CHGCY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 5.3 billion | - | 110.1 million |
| Dec. 31, 2025 | 6.3 billion | - | 114.6 million |
| Sept. 30, 2025 | 6.1 billion | - | 83.1 million |
| June 30, 2025 | 7.1 billion | - | - |
CHGCY Shares Outstanding
CHGCY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 81.0 million | 267.1 million | 155.6 million | - |
| Dec. 31, 2025 | 113.7 million | 387.2 million | 416.1 million | - |
| Sept. 30, 2025 | 71.7 million | 334.1 million | 35.7 million | - |
| June 30, 2025 | 186.5 million | 317.5 million | 197.6 million | - |
CHGCY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 2.1 billion | 591.6 million |
| Dec. 31, 2025 | 2.6 billion | 660.3 million |
| Sept. 30, 2025 | 2.3 billion | 689.1 million |
| June 30, 2025 | 2.0 billion | 612.4 million |
CHGCY
Price: $23.16
52 week price:
Dividend Yield: 3.11%
Payout Ratio Range:
Earnings Per Share: 0.83 USD
P/E Ratio: 30.01
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 86.9 billion